Close



Mar 20, 2024 09:15AM
Mar 20, 2024 09:15AM
Feb 1, 2024 09:00AM
Oct 18, 2023 09:03AM
Apr 12, 2023 09:00AM
Apr 3, 2023 09:05AM
Apr 3, 2023 09:00AM Celularity Receives U.S. Food And Drug Administration (FDA) Preliminary Assessment For Celularity’s Investigational Fuse Bone Void Filler To Be Regulated As A Device By FDA’s Center For Devices An
Feb 2, 2023 07:53AM
Feb 1, 2023 04:06PM
Feb 1, 2023 04:05PM
Jan 26, 2023 04:17PM
Jan 4, 2023 04:10PM
Nov 30, 2022 09:55AM
Nov 10, 2022 04:10PM Celularity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Oct 3, 2022 08:01AM
Oct 3, 2022 08:00AM
Sep 26, 2022 08:01AM
Sep 26, 2022 08:00AM
Aug 9, 2022 04:10PM
Jul 27, 2022 08:00AM
May 16, 2022 04:10PM Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update
Mar 31, 2022 04:05PM
Feb 15, 2022 04:25PM
Feb 15, 2022 04:05PM
Jan 18, 2022 08:00AM
Dec 27, 2021 09:24AM
Dec 27, 2021 09:15AM
Dec 27, 2021 08:01AM Celularity (CELU) Granted FDA Fast Track Designation for NK Cell Therapy CYNK-001 in Development for the Treatment of AML
Dec 27, 2021 08:00AM
Nov 29, 2021 08:03AM
Nov 29, 2021 08:00AM
Sep 15, 2021 08:00AM
Aug 16, 2021 05:15PM
Jul 16, 2021 08:00AM

251,890 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All